Əsas səhifə

Çap

Əks əlaqə

İnfo
Effects and safety of periconceptional folate supplementation for preventing birth defects

Mündəricat

Effects and safety of periconceptional folate supplementation for preventing birth defects

Sübutlu məlumatların xülasələri
09.05.2014 • Sonuncu dəyişiklik 09.05.2014
Editors

Periconceptional folate supplementation is effective for preventing neural tube defects.

Use folic acid before conception and up to 12 weeks of pregnancy for preventing neural tube defects.

A Cochrane review included 5 studies with a total of 5 6105 women. Daily folic acid supplementation (alone or in combination with other vitamins and minerals) prevented NTDs compared with no interventions/placebo or vitamins and minerals without folic acid (RR 0.28, 95% CI 0.15 to 0.52; 5 trials, n=6105). Only one study assessed the incidence of NTDs and the effect was not statistically significant (RR 0.08, 95% CI 0.00 to 1.33) although no events were found in the group that received folic acid. Folic acid had a significant protective effect for reoccurrence of NTD (RR 0.32, 95% CI 0.17 to 0.60; 4 trials, n=1949). Daily dose over 0.4 mg reduced NTDs clearly (RR 0.30, 95% CI 0.16 to 0.56; 4 trials, n=5741), however with dose of 0.36 mg the reduction was not significant (RR 0.12, 95% CI 0.01 to 2.29; 1 trial, n=364). There is no statistically significant evidence of prevention of cleft palate, cleft lip, congenital cardiovascular defects, miscarriages or any other birth defects.

Comment: The level of evidence is downgraded by study quality (unclear allocation concealment and blinding in some studies) and upgraded by large magnitude of effect.

Ədəbiyyat

  1. De-Regil LM, Fernández-Gaxiola AC, Dowswell T, Peña-Rosas JP. Effects and safety of periconceptional folate supplementation for preventing birth defects. Cochrane Database Syst Rev 2010 Oct 6;(10):CD007950.